|
Clinical Characteristics
|
N
|
CTHRC1 expression
|
P value
|
|---|
|
Low
|
High
|
|---|
|
Age
| | | |
0.083
|
|
< 50
|
25
|
9
|
16
| |
|
> 50
|
47
|
27
|
20
| |
|
Histological subtypes
| | | |
0.336
|
|
Mucinous
|
5
|
4
|
1
| |
|
Serous
|
45
|
21
|
24
| |
|
Clear cell
|
4
|
1
|
3
| |
|
Endometrioid
|
16
|
8
|
8
| |
|
Others
|
2
|
2
|
0
| |
|
Tumor grade
| | | |
0.239
|
|
High
|
18
|
7
|
11
| |
|
Medium
|
23
|
10
|
13
| |
|
Low
|
31
|
19
|
12
| |
|
FIGO stage
| | | |
0.018
|
|
I-II
|
34
|
22
|
12
| |
|
III-IV
|
38
|
14
|
24
| |
|
Lymph node metastasis
| | | |
0.001
|
|
Yes
|
24
|
5
|
19
| |
|
No
|
48
|
31
|
17
| |
|
Distance metastasis
| | | |
0.001
|
|
Yes
|
34
|
10
|
24
| |
|
No
|
38
|
26
|
12
| |
|
Ascites-derived cancer cells
| | | |
0.018
|
|
Yes
|
34
|
12
|
22
| |
|
No
|
38
|
24
|
14
| |
- N, number of total samples in group
